会员体验
专利管家（专利管理）
工作空间（专利管理）
风险监控（情报监控）
数据分析（专利分析）
侵权分析（诉讼无效）
联系我们
交流群
官方交流：
QQ群： 891211   
微信请扫码    >>>
现在联系顾问~
下载
著录项
PDF全文
热词
    • 2. 发明授权
      US5486466A Process for the preparation of DNA gyrase inhibitors 失效
    • Process for the preparation of DNA gyrase inhibitors
    • DNA促旋酶抑制剂的制备方法
    • US5486466A
    • 1996-01-23
    • US339442
    • 1994-11-14
    • Mikio Arisawa , Erwin Gotschi , Paul Hebeisen , Tsutomu Kamiyama , Helmut Link , Raffaello Masciadri , Hisao Shimada , Junko Watanabe
    • Mikio Arisawa , Erwin Gotschi , Paul Hebeisen , Tsutomu Kamiyama , Helmut Link , Raffaello Masciadri , Hisao Shimada , Junko Watanabe
    • A61K31/395 , A61K31/42 , A61K31/425 , A61K38/00 , A61P31/04 , C07C317/24 , C07C317/28 , C07C317/46 , C07C317/48 , C07C323/56 , C07C323/58 , C07C323/64 , C07D291/08 , C07D413/04 , C07D413/14 , C07D417/04 , C07D417/14 , C07D419/04 , C07D419/12 , C07K5/02 , C07K5/078 , C07K5/097 , C07K5/103 , C07K7/06 , C12P13/04 , C12N1/20
    • C07D419/04 , C07D291/08 , C07K5/0202 , C07K5/06139 , C07K5/0821 , C07K5/1008 , C07K7/06 , A61K38/00 , Y10S435/886
    • Bicyclic derivatives of the general formula ##STR1## wherein X.sup.1 is --S-- or --SO--;X.sup.2 is --CO-- or --CS--;R.sup.1 is hydrogen, halogen or lower alkyl optionally substituted by halogen or lower alkoxy;R.sup.2 and R.sup.3 are each independently hydrogen, lower alkyl, halogen, amino, lower alkylamino, di-lower alkylamino, acylamino, lower alkexy, lower alkoxymethoxy or a group OR.sup.4 ;R.sup.4 is hydrogen or an easily hydrolyzable group;R.sup.5 is hydrogen, optionally esterified carboxy or amidated (thio)carboxy, optionally substituted alkyl, optionally substituted alkenyl, optionally substituted acyl or heterocyclyl;R.sup.6 and R.sup.7a are each independently hydrogen or lower alkyl;R.sup.7b is hydrogen, optionally substituted hydroxy, --NR--A or --N.dbd.B, in which R is hydrogen or lower alkyl, A is hydrogen, optionally substituted alkyl, lower cycloalkyl, iminoyl, (thio)acyl, esterified carboxy or amidated (thio)carboxy and B is lower alkylidene;R.sup.7a and R.sup.7b together represent oxo, lower alkoxycarbonylmethylidene or optionally substituted hydroxyimino; andR.sup.8 is hydrogen, optionally substituted alkyl, optionally esterified carboxy or amidated (thio)carboxy; provided that no more than two of R.sup.1 -R.sup.3 are nitrogen-containing groups; no more than two of R.sup.1 -R.sup.3 are oxygen containing groups and no more than two of R.sup.1 -R.sup.3 are either nitrogen containing or oxygen containing groups;and pharmaceutically acceptable salts of the compounds of formula I carrying an acidic and/or basic substituent.The products are antimicrobially active.
    • 通式为其中X 1为-S-或-SO-的通式为其的双环衍生物; X2是-CO-或-CS-; R 1为氢，卤素或任选被卤素或低级烷氧基取代的低级烷基; R2和R3各自独立地为氢，低级烷基，卤素，氨基，低级烷基氨基，二低级烷基氨基，酰氨基，低级烷基，低级烷氧基甲氧基或基团OR4; R4是氢或易水解基团; R 5为氢，任选酯化的羧基或酰胺基（硫代）羧基，任选取代的烷基，任选取代的烯基，任选取代的酰基或杂环基; R6和R7a各自独立地为氢或低级烷基; R7b是氢，任选取代的羟基，-NR-A或-N = B，其中R是氢或低级烷基，A是氢，任选取代的烷基，低级环烷基，亚氨酰基，（硫代）酰基，酯化的羧基或酰胺基（ 硫代）羧基，B是低级亚烷基; R7a和R7b一起代表氧代，低级烷氧基羰基亚甲基或任选取代的羟基亚氨基; 和R 8是氢，任选取代的烷基，任选酯化的羧基或酰胺基（硫代）羧基; 条件是R1-R3中不超过两个为含氮基团; R1-R3中不超过两个为含氧基团，R1-R3中不超过两个为含氮基团或含氧基团; 和具有酸性和/或碱性取代基的式I化合物的药学上可接受的盐。 该产品具有抗微生物活性。
    • 基本信息 添加关注 加入工作空间 PDF全文 PDF下载 全文下载 相似专利 双屏查看 权利要求书 说明书全文 Global Dossier Espacenet 法律信息 同族专利 专利引用
    • 5. 发明授权
      US5055572A Cephalosporin derivatives 失效
    • Cephalosporin derivatives
    • CEPHALOSPORIN衍生物
    • US5055572A
    • 1991-10-08
    • US179199
    • 1988-04-08
    • Andre Furlenmeier , Erwin Gotschi , Paul Hebeisen , Werner Hofheinz , Helmut Link
    • Andre Furlenmeier , Erwin Gotschi , Paul Hebeisen , Werner Hofheinz , Helmut Link
    • C07D519/06 , A61K31/545 , A61P31/04 , C07D501/36 , C07D501/46 , C07D519/00
    • C07D501/36 , C07D519/00 , Y02P20/55
    • Acyl derivatives of the formula ##STR1## in which R is an acyl group, excluding those acyl groups of the formula ##STR2## in which A is a group of the formulae --NHCO--, --NHCONHCO--, --NHCOCH.dbd.CH--, ##STR3## wherein R.sup.6 is hydrogen or lower alkyl; R.sup.1 and R.sup.2 are hydrogen or a protecting group, X is hydrogen, halogen, lower alkoxy, nitro or --OR.sup.2, n is 1 or 2, R.sup.4 and R.sup.5 are hydrogen or together represent an additional bond and Z is a direct bond or carbonyl (where R.sup.4 and R.sup.5 both represent hydrogen) or a group of the formula --O--B-- (where R.sup.4 and R.sup.5 together represent an additional bond) in which B is a straight-chain, branched or cyclic lower alkylene;and wherein R.sup.3 is a substituted bicyclic group of the formulae ##STR4## wherein R.sup.7 and R.sup.8 are independently hydrogen, lower alkyl or trifluoromethyl or, in formulae (a), (b), (e) and (f) together represent alkylene with 3 or 4 carbon atoms, and R', R" and R"' are independently hydrogen, lower alkyl or lower cycloalkyl; wherein compounds of formula I in which R.sup.4 and R.sup.5 together represent an additional bond are present in the syn-isomeric form or as a mixture with the anti-isomeric form in which the syn-isomeric form predominates,as well as readily hydrolyzable esters and salts of these compounds and hydrates of the compounds of formula I or of their esters and salts.These compounds are useful as antibiotics.
    • 除了那些其中A是式-NHCO-，-NHCONHCO-，-NHCOCH = CH-的基团的式“IMAGE”的酰基之外，其中R是酰基的式Ⅰ的酰基衍生物， 其中R6是氢或低级烷基; R1和R2是氢或保护基，X是氢，卤素，低级烷氧基，硝基或-OR2，n是1或2，R4和R5是氢或一起代表另外的键，Z是直接键或羰基（ 其中R4和R5都表示氢）或式-BB-（其中R4和R5一起代表附加键）的基团，其中B是直链，支链或环状低级亚烷基; 并且其中R 3是下式的取代的双环基团：其中R 7和R 8独立地是氢，低级烷基或三氟甲基，或者在式（a），（b）中， ），（e）和（f）共同表示具有3或4个碳原子的亚烷基，R'，R“和R”'独立地是氢，低级烷基或低级环烷基; 其中R 4和R 5一起代表另外的键的式Ⅰ化合物以顺式异构形式存在，或作为其中顺式异构体形式占优势的抗异构体形式的混合物以及容易水解的酯和盐 的这些化合物和式I化合物的水合物或它们的酯和盐。 这些化合物可用作抗生素。
    • 基本信息 添加关注 加入工作空间 PDF全文 PDF下载 全文下载 相似专利 双屏查看 权利要求书 说明书全文 Global Dossier Espacenet 法律信息 同族专利 专利引用
    • 6. 发明授权
      US5036064A Cephalosporins with sulfur-containing oxyimino side chain 失效
    • Cephalosporins with sulfur-containing oxyimino side chain
    • 含硫氧基亚氨基侧链的头孢菌素
    • US5036064A
    • 1991-07-30
    • US229960
    • 1988-08-09
    • Erwin Gotschi
    • Erwin Gotschi
    • A61K31/545 , A61K31/546 , A61P31/04 , C07C67/00 , C07C313/00 , C07C317/22 , C07C317/24 , C07C317/46 , C07C323/22 , C07C323/34 , C07C323/35 , C07C323/52 , C07C323/60 , C07C323/61 , C07C323/62 , C07C323/65 , C07C323/66 , C07D277/40 , C07D501/20 , C07D501/22 , C07D501/34 , C07D501/36 , C07D501/46 , C07D501/56
    • C07D501/20 , C07D277/40
    • Antibacterial compounds of the formula ##STR1## wherein R is a mononuclear carbocyclic aromatic group, a 5-membered aromatic heterocyclic group which contains as the hetero (non-carbon) ring member(s) an oxygen or sulphur atom or an imino or lower alkylimino group and, optionally, one or two nitrogen atoms, or a 6-membered aromatic heterocyclic group which contains one to three nitrogen atoms as the hetero ring member(s); R.sup.1 is hydrogen or a 3-substituent which is usable in cephalosporin chemistry; A is lower alkylene or C.sub.3-7 -cycloalkylene which is optionally substituted with carboxy, carbamoyl, lower alkylcarbamoyl or di(lower alkyl)carbamoyl; Q is lower alkylene or C.sub.3-7 -cycloalkylene which is optionally substituted with carboxy, carbamoyl, lower alkylcarbamoyl or di(lower alkyl)carbamoyl, or the group --NR.sup.2 -- or --NR.sup.2 NR.sup.3 --; R.sup.2 and R.sup.3 are independently hydrogen or lower alkyl; p and m are the zero or 1, n is zero, 1 or 2; R.sup.4 is hydrogen, lower alkanoyl or tri(lower alkyl)silyl; two R.sup.4 groups together represent diphenylmethylene; R.sup.5 is hydrogen, lower alkyl, hydroxy, lower alkoxy, halogen, nitro, --OCOR.sup.7, --OCOOR.sup.71, --N(R.sup.7).sub.2, --NHCOR.sup.7, --NHCOOR.sup.71, --COR.sup.7, --SR.sup.7, --SOR.sup.7, --SO.sub.2 R.sup.7, --SO.sub.3 H, --COOR.sup.7 or --CON(R.sup.7).sub.2 ; R.sup.6 is hydrogen, lower alkyl or halogen, R.sup.7 is hydrogen or lower alkyl; R.sup.71 is lower alkyl, and the two --OR.sup.4 groups are attached to the phenyl ring via adjacent carbon atoms, as well as readily hydrolyzable esters and pharmaceutically acceptable salts of these compounds and hydrates of compounds of formula I and of their esters and salts.
    • 其中R是单核碳环芳族基团，含有作为杂（非碳）环成员的氧或硫原子的亚烷基或低级的5元芳族杂环基的抗菌化合物 烷基亚氨基和任选的一个或两个氮原子，或含有1-3个氮原子作为杂环成员的6元芳族杂环基; R1是氢或可用于头孢菌素化学的3-取代基; A是低级亚烷基或任选被羧基，氨基甲酰基，低级烷基氨基甲酰基或二（低级烷基）氨基甲酰基取代的C 3-7 - 亚环烷基; Q是低级亚烷基或任选被羧基，氨基甲酰基，低级烷基氨基甲酰基或二（低级烷基）氨基甲酰基取代的C 3-7 - 亚环烷基，或-NR2-或-NR2NR3-基团。 R2和R3独立地是氢或低级烷基; p和m为零或1，n为零，1或2; R4是氢，低级烷酰基或三（低级烷基）甲硅烷基; 两个R 4基团一起表示二苯基亚甲基; R5是氢，低级烷基，羟基，低级烷氧基，卤素，硝基，-OCOR7，-OCOOR71，-N（R7）2，-NHCOR7，-NHCOOR71，-COR7，-SR7，-SOR7，-SO2R7，-SO3H， -COOR7或-CON（R7）2; R6是氢，低级烷基或卤素，R7是氢或低级烷基; R71是低级烷基，并且两个-OR4基团通过相邻的碳原子连接到苯环上，以及这些化合物的易水解的酯和药学上可接受的盐以及式I化合物及其酯和盐的水合物。
    • 基本信息 添加关注 加入工作空间 PDF全文 PDF下载 全文下载 相似专利 双屏查看 权利要求书 说明书全文 Global Dossier Espacenet 法律信息 同族专利 专利引用
    • 8. 发明授权
      US5319140A Intermediates for cephalosporins with sulfur containing oxyimino side chain 失效
    • Intermediates for cephalosporins with sulfur containing oxyimino side chain
    • 含硫氧基亚氨基侧链的头孢菌素中间体
    • US5319140A
    • 1994-06-07
    • US885581
    • 1992-05-19
    • Erwin Gotschi
    • Erwin Gotschi
    • A61K31/545 , A61K31/546 , A61P31/04 , C07C67/00 , C07C313/00 , C07C317/22 , C07C317/24 , C07C317/46 , C07C323/22 , C07C323/34 , C07C323/35 , C07C323/52 , C07C323/60 , C07C323/61 , C07C323/62 , C07C323/65 , C07C323/66 , C07D277/40 , C07D501/20 , C07D501/22 , C07D501/34 , C07D501/36 , C07D501/46 , C07D501/56 , C07C321/24
    • C07D501/20 , C07D277/40
    • Antibacterial compounds of the formula ##STR1## wherein R is a mononuclear carbocyclic aromatic group, a 5-membered aromatic heterocyclic group which contains as the hereto (non-carbon) ring member(s) an oxygen or sulphur atom or an imino or lower alkylimino group and, optionally, one or two nitrogen atoms, or a 6-membered aromatic heterocyclic group which contains one to three nitrogen atoms as the hereto ring member(s); R.sup.1 is hydrogen or a 3-substituent which is usable in cephalosporin chemistry; A is lower alkylene or C.sub.3-7 -cycloalkylene which is optionally substituted with carboxy, carbamoyl, lower alkylcarbamoyl or di(lower alkyl)carbamoyl; Q is lower alkylene or C.sub.3-7 -cycloalkylene which is optionally substituted with carboxy, carbamoyl, lower alkylcarbamoyl or di(lower alkyl)carbamoyl or the group --NR.sup.2 -- or --NR.sup.2 NR.sup.3 --; R.sup.2 and R.sup.3 are independently hydrogen or lower alkyl; p and m are the zero or 1, n is zero, 1 or 2; R.sup.4 is hydrogen, lower alkanoyl or tri(lower alkyl)silyl; two R.sup.4 groups together represent diphenylmethylene; R.sup.5 is hydrogen, lower alkyl, hydroxy, lower alkoxy, halogen, nitro, --OCOR.sup.7, --OCOOR.sup.71, --N(R.sup.7).sub.2, --NHCOR.sup.7, --NHCOOR.sup.71, --COR.sup.7, --SR.sup.7, --SOR.sup.7, --SO.sub.2 R.sup.7, --SO.sub.3 H, --COOR.sup.7 or --CON(R.sup.7).sub.2 ; R.sup.6 is hydrogen, lower alkyl or halogen, R.sup.7 is hydrogen or lower alkyl; R.sup.71 is lower alkyl, and the two --OR.sup.4 groups are attached to the phenyl ring via adjacent carbon atoms, as well as readily hydrolyzable esters and pharmaceutically acceptable salts of these compounds and hydrates of compounds of formula I and of their esters and salts.
    • 其中R是单核碳环芳族基团的5元芳族杂环基团，其中含有氧原子或硫原子或亚氨基或低级亚烷基的非芳族杂环基团 烷基亚氨基和任选的一个或两个氮原子，或含有一至三个氮原子的6-元芳族杂环基作为本文的环成员; R1是氢或可用于头孢菌素化学的3-取代基; A是低级亚烷基或任选被羧基，氨基甲酰基，低级烷基氨基甲酰基或二（低级烷基）氨基甲酰基取代的C 3-7 - 亚环烷基; Q是低级亚烷基或任选被羧基，氨基甲酰基，低级烷基氨基甲酰基或二（低级烷基）氨基甲酰基或-NR 2 - 或-NR 2 NR 3 - 基团取代的C 3-7 - 亚环烷基; R2和R3独立地是氢或低级烷基; p和m为零或1，n为零，1或2; R4是氢，低级烷酰基或三（低级烷基）甲硅烷基; 两个R 4基团一起表示二苯基亚甲基; R5是氢，低级烷基，羟基，低级烷氧基，卤素，硝基，-OCOR7，-OCOOR71，-N（R7）2，-NHCOR7，-NHCOOR71，-COR7，-SR7，-SOR7，-SO2R7，-SO3H， -COOR7或-CON（R7）2; R6是氢，低级烷基或卤素，R7是氢或低级烷基; R71是低级烷基，并且两个-OR4基团通过相邻的碳原子连接到苯环上，以及这些化合物的易水解的酯和药学上可接受的盐以及式I化合物及其酯和盐的水合物。
    • 基本信息 添加关注 加入工作空间 PDF全文 PDF下载 全文下载 相似专利 双屏查看 权利要求书 说明书全文 Global Dossier Espacenet 法律信息 同族专利 专利引用
    • 9. 发明授权
      US5138066A Intermediates for cephalosporins with sulfur-containing oxyimino side chain 失效
    • Intermediates for cephalosporins with sulfur-containing oxyimino side chain
    • 含硫氧基亚氨基侧链的头孢菌素中间体
    • US5138066A
    • 1992-08-11
    • US728448
    • 1991-07-11
    • Erwin Gotschi
    • Erwin Gotschi
    • C07D277/40 , C07D501/20
    • C07D501/20 , C07D277/40
    • Antibacterial compounds of the formula ##STR1## wherein R is a mononuclear carbocyclic aromatic group, a 5-membered aromatic heterocyclic group which contains as the hetero (non-carbon) ring member(s) an oxygen or sulphur atom or an imino or lower alkylimino group and, optionally, one or two nitrogen atoms, or a 6-membered aromatic heterocyclic group which contains one to three nitrogen atoms as the hetero ring member(s); R.sup.1 is hydrogen or a 3-substituent which is usable in cephalosporin chemistry; A is lower alkylene or C.sub.3-7 -cycloalkylene which is optionally substituted with carboxy, carbamoyl, lower alkylcarbamoyl or di(lower alkyl)carbamoyl; Q is lower alkylene or C.sub.3-7 -cycloalkylene which is optionally substituted with carboxy, carbamoyl, lower alkylcarbamoyl or di(lower alkyl)carbamoyl, or the group --NR.sup.2 -- or --NR.sup.2 NR.sup.3 --; R.sup.2 and R.sup.3 are independently hydrogen or lower alkyl; p and m are the zero or 1, n is zero, 1 or 2; R.sup.4 is hydrogen, lower alkanoyl or tri(lower alkyl)silyl; two R.sup.4 groups together represent diphenylmethylene; R.sup.5 is hydrogen, lower alkyl, hydroxy, lower alkoxy, halogen, nitro, --OCOR.sup.7, --OCOOR.sup.71, --N(R.sup.7).sub.2, --NHCOR.sup.7, --NHCOOR.sup.71, --COR.sup.7, --SR.sup.7, --SOR.sup.7, --SO.sub.2 R.sup.7, --SO.sub.3 H, --COOR.sup.7 or --CON(R.sup.7).sub.2 ; R.sup.6 is hydrogen, lower alkyl or halogen, R.sup.7 is hydrogen or lower alkyl; R.sup.71 is lower alkyl, and the two --OR.sup.4 groups are attached to the phenyl ring via adjacent carbon atoms,as well as readily hydrolyzable esters and pharmaceutically acceptable salts of these compounds and hydrates of compounds of formula I and of their esters and salts.
    • 其中R是单核碳环芳族基团，含有作为杂（非碳）环成员的氧或硫原子的亚烷基或低级的5元芳族杂环基的抗菌化合物 烷基亚氨基和任选的一个或两个氮原子，或含有1-3个氮原子作为杂环成员的6元芳族杂环基; R1是氢或可用于头孢菌素化学的3-取代基; A是低级亚烷基或任选被羧基，氨基甲酰基，低级烷基氨基甲酰基或二（低级烷基）氨基甲酰基取代的C 3-7 - 亚环烷基; Q是低级亚烷基或任选被羧基，氨基甲酰基，低级烷基氨基甲酰基或二（低级烷基）氨基甲酰基取代的C 3-7 - 亚环烷基，或-NR2-或-NR2NR3-基团。 R2和R3独立地是氢或低级烷基; p和m为零或1，n为零，1或2; R4是氢，低级烷酰基或三（低级烷基）甲硅烷基; 两个R 4基团一起表示二苯基亚甲基; R5是氢，低级烷基，羟基，低级烷氧基，卤素，硝基，-OCOR7，-OCOOR71，-N（R7）2，-NHCOR7，-NHCOOR71，-COR7，-SR7，-SOR7，-SO2R7，-SO3H， -COOR7或-CON（R7）2; R6是氢，低级烷基或卤素，R7是氢或低级烷基; R71是低级烷基，并且两个-OR4基团通过相邻的碳原子连接到苯环上，以及这些化合物的易水解的酯和药学上可接受的盐以及式I化合物及其酯和盐的水合物。
    • 基本信息 添加关注 加入工作空间 PDF全文 PDF下载 全文下载 相似专利 双屏查看 权利要求书 说明书全文 Global Dossier Espacenet 法律信息 同族专利 专利引用
    • 10. 发明授权
      US5073550A Cephalosphorins with sulfur-containing oxyimino side chain 失效
    • Cephalosphorins with sulfur-containing oxyimino side chain
    • 头孢菌素含硫氧基亚氨基侧链
    • US5073550A
    • 1991-12-17
    • US574329
    • 1990-08-28
    • Erwin Gotschi
    • Erwin Gotschi
    • C07D277/40 , C07D501/20
    • C07D501/20 , C07D277/40
    • Antibacterial compounds of the formula ##STR1## wherein R is a mononuclear carbocyclic aromatic group, a 5-membered aromatic heterocyclic group which contains as the hetero (non-carbon) ring member(s) an oxygen or sulphur atom or an imino or lower alkylimino group and, optionally, one or two nitrogen atoms, or a 6-membered aromatic heterocyclic group which contains one to three nitrogen atoms as the hetero ring member(s); R.sup.1 is hydrogen or a 3-substituent which is usable in cephalosporin chemistry; A is lower alkylene or C.sub.3-7 cycloalkylene which is optionally substituted with carboxy, carbamoyl, lower alkylcarbamoyl or di-(lower alkyl)carbamoyl; Q is lower alkylene or C.sub.3-7 cycloalkylene which is optionally substituted with carboxy, carbamoyl, lower alkylcarbamoyl or di(lower alkyl)carbamoyl, or the group --NR.sup.2 -- or --NR.sup.2 NR.sup.3 --; R.sup.2 and R.sup.3 are independently hydrogen or lower alkyl; p and m are the zero or 1, n is zero, 1 or 2; R.sup.4 is hydrogen, lower alkanoyl or tri(lower alkyl)silyl; two R.sup.4 groups together represent diphenylmethylene; R.sup.5 is hydrogen, lower alkyl, hydroxy, lower alkoxy, halogen, nitro, --OCOR.sup.7, --OCOOR.sup.71, --N(R.sup.7).sub.2, --NHCOR.sup.7, --NHCOOR.sup.71, --COR.sup.7, --SR.sup.7, --SOR.sup.7, --SO.sub.2 R.sup.7, --SO.sub.3 H, --COOR.sup.7 or --CON(R.sup.7).sub.2 R.sup.6 is hydrogen, lower alkyl or halogen, R.sup.7 is hydrogen or lower alkyl; R.sup.71 is lower alkyl, and the two --OR.sup.4 groups are attached to the phenyl ring via adjacent carbon atoms,as well as readily hydrolyzable esters and pharmaceutically acceptable salts of these compounds and hydrates of compounds of formula I and of their esters and salts.
    • 其中R是单核碳环芳族基团，含有作为杂（非碳）环成员的氧或硫原子的亚烷基或低级的5元芳族杂环基的抗菌化合物 烷基亚氨基和任选的一个或两个氮原子，或含有1-3个氮原子作为杂环成员的6元芳族杂环基; R1是氢或可用于头孢菌素化学的3-取代基; A是低级亚烷基或任选被羧基，氨基甲酰基，低级烷基氨基甲酰基或二 - （低级烷基）氨基甲酰基取代的C 3-7亚环烷基; Q是低级亚烷基或任选被羧基，氨基甲酰基，低级烷基氨基甲酰基或二（低级烷基）氨基甲酰基取代的C 3-7亚环烷基，或-NR2-或-NR2NR3-基团。 R2和R3独立地是氢或低级烷基; p和m为零或1，n为零，1或2; R4是氢，低级烷酰基或三（低级烷基）甲硅烷基; 两个R 4基团一起表示二苯基亚甲基; R5是氢，低级烷基，羟基，低级烷氧基，卤素，硝基，-OCOR7，-OCOOR71，-N（R7）2，-NHCOR7，-NHCOOR71，-COR7，-SR7，-SOR7，-SO2R7，-SO3H， -COOR 7或-CON（R 7）2 R 6是氢，低级烷基或卤素，R 7是氢或低级烷基; R71是低级烷基，并且两个-OR4基团通过相邻的碳原子连接到苯环上，以及这些化合物的易水解的酯和药学上可接受的盐以及式I化合物及其酯和盐的水合物。
    • 基本信息 添加关注 加入工作空间 PDF全文 PDF下载 全文下载 相似专利 双屏查看 权利要求书 说明书全文 Global Dossier Espacenet 法律信息 同族专利 专利引用
每页展示10个专利
每页展示10个专利
每页展示20个专利
每页展示50个专利
每页展示100个专利

IPRDB

最新中国发明专利 最新美国发明专利 技术领域 专利库 专利分类库 国际专利分类库

热门服务

会员版试用 API 数据接口 找代理 知嘟嘟专利交易 排行榜 大学排行榜 专利百科

关于我们

平台介绍 战略合作 网站地图

友情链接

知嘟嘟专利交易 国家知识产权局 中国商标网

联系方式


©2019-2023 上海吉码数字技术有限公司 版权所有，并保留所有权利 沪ICP备20016256号-6 沪公网安备31011702005475号